IPP Bureau
USFDA grants priority review to Roche’s Actemra/RoActemra to treat Covid-19
By IPP Bureau - April 04, 2022
If approved, it will be the first USFDA-approved immunomodulator for the treatment of Covid-19 in hospitalised patients
Good microbiome and probiotics key to good health
By IPP Bureau - April 04, 2022
The symposium was organized by the Gut Microbiota and Probiotic Science Foundation (India) and Medanta Institute of Education and Research, Gurugram, and Amity University, Gurugram
Merck expands manufacturing facility in Virginia to increase HPV vaccine supply
By IPP Bureau - April 04, 2022
Supply increase to help meet growing global demand
Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board
By IPP Bureau - April 04, 2022
Sanofi’s DE&I Board will include three of the most influential voices in the DE&I space as Board members appointed for 3 years: organizational psychologist & best-selling author John Amaechi, award-winning social entrepreneur Caroline Casey, and DE&I pioneer and renowned thought-leader Dr. Rohini Anand
FirstCure, a healthcare startup that simplifies surgeries
By IPP Bureau - April 04, 2022
It aims to make the state-of-the-art modern and safe surgical care, typically available in super-speciality hospitals of big cities, accessible, affordable, standardized and integrated
Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar
By IPP Bureau - April 04, 2022
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
International Virchow Prize for Global Health launched
By IPP Bureau - April 04, 2022
Highly prestigious award endowed with €500,000 to uphold the United Nations 2030 Agenda
Siemens Healthineers expands its manufacturing footprint under PLI scheme
By IPP Bureau - April 04, 2022
The company inaugurated the new production line at the Bengaluru facility to manufacture Computed Tomography Scanners
Croda secures financial support from UK Government for expansion of lipid systems manufacturing facility
By IPP Bureau - April 04, 2022
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
Bayer to invest €1.3 billion for driving innovations in life sciences, agriculture segment
By IPP Bureau - April 03, 2022
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
WHO suspends supply of Covaxin under Covax facility
By IPP Bureau - April 03, 2022
WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility
JBCPL buys Azmarda trademark for India at Rs 246 crore
By IPP Bureau - April 03, 2022
The brand Azmarda fits well with JBCPL's overall strategy of strengthening its presence in the cardiology segment in India.
Blue Star opens medical diagnostic equipment refurbishment facility in Maharashtra
By IPP Bureau - April 03, 2022
Through this new set-up, the company intends to make available, affordable high-quality medical diagnostic imaging equipment across Tier 2, 3, and 4 towns in India
Panacea Biotec appoints NK Juneja as additional director
By IPP Bureau - April 03, 2022
He has done his Masters in Pharmacy (M. Pharm) and Post Graduate Diploma in Personnel Management & Industrial Relations
Jubilant Pharmova to acquire stake in Greencure
By IPP Bureau - April 03, 2022
There is also a strong synergy between Jubilant and Greencure with respect to OTC portfolio which can be explored for R&D, online acceleration and offline distribution
